Anglo-French Drugs & Industries Ltd
- Thinly traded share
- Healthcare
- ISIN INE570E01016
At a glance
Sales
FY26
₹90.32 Cr
+2.9%on FY25What the company earned from its customers in the year.
Profit
FY26
₹22.81 Cr
+216%on FY25What was left after every cost and tax was paid.
Market valuecalculated
₹179 Cr
What the whole company would be worth at GrowFast's indicative price.
Net worth
FY26
₹147 Cr
What the owners would have left on paper if every debt was repaid.
From the company's published figures; sources are beside each figure further down the page.
Key details
- Company
- Anglo-French Drugs & Industries Ltd
- ISIN
- INE570E01016
- Sector
- Healthcare
- Type of share
- Equity share (see listing status)
- Indicative price per share
- ₹1,585.24
- Price last updated
- 12 Oct 2026
- Minimum quantity
- Confirmed by the desk
- How you hold it
- In your own demat account
- Enquiries
- GrowFast desk, on WhatsApp
Indicative prices, illiquid shares. Prices are indicative and can change without notice. Unlisted shares are illiquid: you may not be able to sell when you want to, or at the price shown.
Company
About Anglo-French Drugs & Industries Ltd
Anglo-French Drugs & Industries makes, sells and distributes pharmaceutical formulations and nutraceutical dietary supplements, with its plant at Peenya, Bengaluru. It is controlled by the Kanoria family: the Abhay Kanoria Family Trust holds about 54% and group company Broach Textiles Mills about 10%. A large part of its balance sheet is financial investments, and the board has approved a demerger of those investments into a new company, AFD Enterprises Limited, which is pending before the NCLT.
Written from: afdil.com
Listing status. Already listed: the equity shares are listed on the Metropolitan Stock Exchange of India (MSE). The annual report says the scrip is in the Special Pre-Open Session category with price not discovered. Annual Report 2025-26 (company website)
Financials
Ask for the full annual report.
The figures on this page are the headline numbers. The desk can share the latest annual report and anything published since.
Ask for the financials- Sector
- Healthcare
- ISIN
- INE570E01016
- Year of incorporation
- 1923
- Registered office
- Mumbai, Maharashtra (head office and plant at Peenya, Bengaluru, Karnataka)
- Promoters
- Kanoria family: Abhay Kanoria Family Trust (54.12%), Broach Textiles Mills Limited (10.39%) and others
- Key people
- Chairman: Abhay Kanoria; Managing Directors: Uddhav Abhay Kanoria and Nirbhay Abhay Kanoria; CFO: Manik Kumar Singh
- Permanent employees
- 153 people
- Face value per share
- ₹10
- Equity shares outstanding
- 11,26,882 shares
- CIN
- L24230MH1923PLC463682
- Website
- afdil.com
Read from: Annual Report 2025-26 (company website), unless another source is shown on a card.
Key data
What the numbers mean
The ratios buyers look at, each said in plain words.
Price to earnings (P/E)calculated
7.8×
At this price you pay ₹7.8 for every ₹1 of profit the company made in the year.
Price to book (P/B)calculated
1.21×
At this price you pay ₹1.21 for every ₹1 of net worth on the company's books.
Profit margincalculated
25.3%
Out of every ₹100 of sales, ₹25.3 was left as profit.
Return on equitycalculated
15.5%
For every ₹100 of the owners' money, the company made ₹15.5 of profit in the year.
Debt to equitycalculated
0.15×
The company has borrowed ₹0.15 for every ₹1 of its owners' money.
- Indicative price
- ₹1,585.24
- Market valuecalculated
- ₹179 Cr
- price × shares
- No. of shares
- 11,26,882
- EPS
- ₹202
- Book value per share
- ₹1,308.83
- Face value
- ₹10
Figures marked “calculated” are worked out by GrowFast from its indicative price and the company's published figures for FY2025-26. They move with the price, and they are arithmetic, not a valuation.
Figures in ₹ crore
Financials
Anglo-French Drugs & Industries Limited. As published in the company's audited reports. GrowFast has not audited them.
Sales, year by year
₹ crore. The darkest bar is the latest year.
FY23 to FY26: ₹103 Cr to ₹90.32 Cr.
Profit, year by year
₹ crore, after tax. A bar below the line is a loss.
FY23 to FY26: ₹191 Cr to ₹22.81 Cr.
| Particulars | FY23 | FY24 | FY25 | FY26Latest |
|---|---|---|---|---|
| Revenue from operations | 102.51 | 95.2 | 87.79 | 90.32▲3% |
| Other income | 7.59 | 4.64 | 30.2 | 39.07▲29% |
| Total income | 110.1 | 99.84 | 117.99 | 129.39▲10% |
| Depreciation and amortisation | 3.34 | 3.15 | 3.27 | 3.28 |
| Finance costs | 3.07 | 1.85 | 1.78 | 2.02▲13% |
| Profit before tax (after exceptional income of ₹291.27 crore) | 251.08 | -12.29 | 7.93 | 22.77▲187% |
| Profit after tax | 190.94 | -12.34 | 7.22 | 22.81▲216% |
| Earnings per share (basic and diluted) (₹) | 1,478 | -99 | 62 | 202▲226% |
Rupees crore unless marked, standalone. The change shown is the latest year against the year before. Read from: Annual Report 2023-24 (company website), Annual Report 2025-26 (company website).
Ownership
Shareholding pattern
Who owns the company
As of 31 March 2026
54.1%Abhay Kanoria Family Trust (promoter)
- Largest holder
- 54.1%
- Top 3 together
- 71.5%
- Holders named
- 5
- Abhay Kanoria Family Trust (promoter)54.12%
- Broach Textiles Mills Limited (promoter group)10.39%
- Life Insurance Corporation of India7.04%
- Prabhadevi Kanoria (promoter group)0.31%
- Binod Kumar Kanoria (HUF) (promoter group)0.02%
- Total71.88%
Read from: Annual Report 2025-26 (company website)
Capital history
Fund raise history
| Date and detail | Type | Instrument | Price per share | Amount raised |
|---|---|---|---|---|
| 23 Sept 2024Bought back 1,06,500 shares (about 8.63% of the equity) at ₹4,000 each; consideration settled 23 September 2024 and shares extinguished 1 October 2024. | Buyback | Equity shares | ₹4,000 | ₹43 Cr |
| 14 Aug 2023Bought back 58,118 shares (4.5% of the equity) at ₹3,100 each for ₹18,01,65,800; consideration settled 14 August 2023. | Buyback | Equity shares | ₹3,100 | ₹18 Cr |
Read from: Annual Report 2025-26 (company website)
Leadership
Management
Abhay Kanoria
Chairman
Uddhav Abhay Kanoria
Managing Director
Nirbhay Abhay Kanoria
Managing Director
Manik Kumar Singh
Chief Financial Officer
Sriee Aneetha M
Company Secretary
Rani Shokeen
Independent Director
Srinivasan Krishnan
Independent Director
Pradeep Vasantarao Joshi
Independent Director
Read from: Annual Report 2025-26 (company website)
Corporate calendar
Events
- 17 Sept 2026AGM103rd AGM called for 17 September 2026; final dividend of ₹1.50 per share for FY2025-26 proposedOpen
- 15 Jul 2026DemergerJoint application for the demerger scheme with AFD Enterprises Limited filed before NCLT Mumbai after MSE no-objectionOpen
- 20 May 2026Board meetingBoard approved audited results for the year ended 31 March 2026Open
- 15 Jan 2026Registered officeRegistered office moved to Prabhadevi, MumbaiOpen
- 12 Sept 2025DemergerBoard approved a scheme of arrangement to demerge into AFD Enterprises Limited (resulting company)Open
- 11 Aug 2025AGM102nd AGM; final dividend of ₹1.50 per share for FY2024-25Open
- 5 Jun 2025Postal ballotShareholders approved shifting the registered office from Karnataka to MaharashtraOpen
- 21 Aug 2024EGMShareholders approved buyback of 1,06,500 shares at ₹4,000 eachOpen
Reports and filings
Annual reports and results
Each link opens the document where its publisher keeps it.
Before you buy
Six things to check on any unlisted share.
The same list applies to every stock. None of it is advice on this one.
The company's latest financials
Revenue, profit and debt for the last three years, from its audited annual report. Ask the desk for the most recent set.
What the price implies
Compare the price per share with earnings and book value per share, and with listed companies in the same business.
Whether a listing is planned
A company may file for an IPO, delay it or never list. A listing, its timing and its price are never certain.
How you would sell
There is no exchange for these shares. You sell by finding a buyer, which can take time and may be at a lower price.
Lock-in after a listing
Shares bought before an IPO are usually locked in for a period after the company lists. Confirm the current rule before you buy.
Tax on your gains
Unlisted shares are taxed differently from listed ones. Check your position with a tax adviser.
Questions
What buyers ask about this stock.
Not answered here? Ask the desk.
Inquire about Anglo-French Drugs & Industries Ltd on WhatsAppIs the price shown for Anglo-French Drugs & Industries Ltd final?
No. It is an indicative price per share. The desk confirms the price and the quantity available when you inquire, and the confirmed price is the one you deal at.
How do I buy these shares?
Press Inquire. It opens a WhatsApp chat with the desk, with this stock already named. After the price and quantity are agreed, a 10% advance locks the deal. Once your KYC is complete you pay the balance, and the shares are transferred to your demat account.
Do I pay anything on this website?
No. No payment is taken and no order is placed on this site. Payment details are shared by the desk only after the deal is agreed.
What do I need before I can buy?
A demat account in your name and the documents for KYC: your identity and demat account details are verified before any deal, as the regulations require.
Can I sell my Anglo-French Drugs & Industries Ltd shares to GrowFast?
GrowFast buys as well as sells. Press Inquire and tell the desk how many shares you hold; it will come back with what it can offer.
How do I sell Anglo-French Drugs & Industries Ltd shares I already hold?
Tell the desk how many you hold. If a price is agreed, you transfer the shares from your demat account with a delivery instruction to your depository participant (a DIS, or its online equivalent), and payment follows as agreed with the desk.
Is there a lock-in if the company lists?
Shares held before an IPO are generally locked in for a period after the listing under SEBI's rules, which have changed over time. Ask the desk for the rule that applies today before you buy.
Is buying unlisted shares legal in India?
Yes. Shares of an unlisted company can be bought and sold privately and are transferred between demat accounts. They are not traded on a stock exchange, so the protections of an exchange do not apply.
What is the minimum I can buy?
It differs by stock and by what the desk holds at the time. The desk confirms the minimum quantity when you inquire.
What is an ISIN?
The 12-character code that identifies a security. It is how your depository knows exactly which share is being transferred to your demat account.
Why are unlisted shares riskier than listed ones?
Prices are indicative and can change without notice. Unlisted shares are illiquid: you may not be able to sell when you want to, or at the price shown.
Similar stocks
More in Healthcare
- API Holdings Ltd (PharmEasy)₹6.46 · ₹4,539 Cr
- Dantech Digital Dental Solutions Private Limited₹445.50
- Down Town Hospital Limited₹371.25
- Gynofem Healthcare and Pharmaceutical₹63.36
- Hicks Thermometers India Limited₹1,633.50 · ₹45 Cr · P/E 8.1
- Lakeshore Hospital and Research Centre₹97.02 · ₹970 Cr · P/E 18.3
Risk disclosure
Prices on this site are indicative, quoted per share, and are not an offer to buy or sell. The price and quantity for any deal are confirmed by GrowFast's desk at the time you deal.
Unlisted, pre-IPO and delisted shares are not traded on a stock exchange. They are illiquid, their prices can move sharply, and you may be unable to sell them when you wish or at all. A company that is expected to list may not do so.
Nothing on this site is investment advice or a promise of returns. Past prices do not predict future prices. Consider your own circumstances, and take independent advice, before you invest.
Inquire opens a WhatsApp chat with GrowFast. No payment is taken and no order is placed on this site.
GrowFast is not affiliated with, sponsored by or endorsed by Anglo-French Drugs & Industries Ltd. Its name and logo belong to their owner and are shown only to identify the company. Figures about it come from published sources and have not been audited by GrowFast. See the Terms and Conditions.